Skip to main content

Gestational Diabetes as a Proxy for Maternal and Child Neurodivergence

Gestational Diabetes as a Proxy for Maternal and Child Neurodivergence

Recent research often reports an association between gestational diabetes and later diagnoses of autism or ADHD in children. At first glance, this can look like causation — but a closer look suggests that gestational diabetes is more likely a proxy for maternal neurodivergence rather than the root cause.

Key Points

  • Genetic/Epigenetic Inheritance: Autism and ADHD are ~70–80% heritable. A neurodiverse mother passes on this genetic liability directly to her child, regardless of pregnancy complications.
  • Maternal Metabolic Risk: Women with autism or ADHD show higher prevalence of type 2 diabetes, prediabetes, and gestational diabetes due to overlapping biological and lifestyle factors.
  • Observed Correlation: Large population studies find links between gestational diabetes and child neurodivergence. However, this is often a confounded correlation — gestational diabetes acts as a marker of maternal neurodivergence, not the cause of the child’s autism/ADHD.

Critique of Por et al. (EASD 2025)

Published in “Gestational diabetes and maternal and offspring neurocognitive dysfunction”
 Diabetologia 68 (Suppl 1), 2025, Abstract 774. doi:10.1007/s00125-025-06497-1

Summary of Findings

Por et al. conducted a systematic review and meta-analysis of 54 observational studies (6 maternal, 48 offspring) examining the association between gestational diabetes mellitus (GDM) and neurocognitive outcomes. They report:

  • Mothers with prior GDM scored ~2.5 points lower on the Montreal Cognitive Assessment (MoCA).

  • Offspring of GDM pregnancies had modestly lower IQ (~4 points) and verbal crystallized intelligence, and reduced BDNF levels.

  • Modest increases in relative risk for developmental delay (RR 1.45), ADHD (RR 1.36), and ASD (RR 1.56).

  • No significant differences in major brain structures or global screening tests (Bayley, ASQ).

The authors conclude that GDM is associated with neurocognitive decline in both mothers and offspring, and call for further research.

Strengths

  • Systematic review across multiple databases with transparent inclusion criteria.

  • Focus on both maternal and intergenerational outcomes.

  • Use of adjusted effect estimates and standard meta-analytic methodology.

  • Large pooled sample across decades of research.

Limitations

  1. Observational evidence only: All included studies were observational. No randomized or quasi-experimental designs were available, meaning causality cannot be inferred.

  2. Residual confounding: While adjustments were made, few studies controlled for maternal neurodevelopmental conditions (e.g. autism, ADHD) that are:

    • highly heritable (~70–80%),

    • strongly associated with increased diabetes risk (type 2 and gestational),

    • directly transmitted to offspring.
      This unmeasured confounding may explain much of the observed association.

  3. Effect size interpretation: Differences of 3–4 IQ points, while statistically significant, are small compared with known variation from socioeconomic status, education, and genetics.

  4. Heterogeneity of measures: Outcomes ranged from IQ tests to biomarkers to broad developmental screening, complicating interpretation.

  5. Publication bias: Positive associations are more likely to be published, especially in this high-interest area.

Alternative Interpretation

Rather than direct intrauterine causation, the association between GDM and offspring neurocognitive outcomes may reflect shared genetic and epigenetic liability:

  • Maternal neurodivergence (autism/ADHD traits) increases risk of both diabetes and gestational diabetes.

  • The same maternal genetic factors are inherited by offspring, accounting for elevated risks of ADHD/ASD.

  • GDM therefore functions as a proxy marker of maternal neurodivergence rather than a causal exposure.

This interpretation is supported by family and sibling-comparison designs in related research, which often find attenuation of effect estimates once genetic background is controlled.

Balanced Conclusion

Por et al. provide evidence of an association between GDM and offspring neurocognitive outcomes, but the design cannot disentangle causal intrauterine effects from shared genetic confounding. The most parsimonious explanation is that maternal neurodivergence (autism/ADHD) increases both diabetes risk and transmission of neurodevelopmental traits to offspring, with GDM serving primarily as a proxy.

Future work should employ genetically informed designs (e.g. sibling comparisons, polygenic risk scores, Mendelian randomization) to clarify whether GDM exerts an independent causal influence, or whether it is largely a statistical red herring.

 

References

Summary: Gestational diabetes in pregnancy is better understood as a red herring or proxy for maternal neurodivergence. It reflects underlying genetic and metabolic factors rather than causing autism or ADHD in children. Correlation is not causation. Neurodiverse mothers will tend to have (80% genetic/epigenetic heritability) neurodiverse kids. Neurodiversity is a risk factor for diabetes.

Comments

Post a Comment

Popular posts from this blog

The Nobel Prize for Peripheral Immune Tolerance: What It Might Mean for Neurodiversity and Childhood Cancer

The Nobel Prize for Peripheral Immune Tolerance: What It Might Mean for Neurodiversity and Childhood Cancer A Nobel Moment for the Immune System The 2025 Nobel Prize in Physiology or Medicine went to Mary Brunkow , Fred Ramsdell , and Shimon Sakaguchi for their discoveries concerning peripheral immune tolerance  — how the immune system restrains itself from attacking the body’s own tissues. Their work put a bright spotlight on regulatory T cells (Tregs) and the FOXP3 gene, the master regulator of Treg identity.  First, to ground what was just awarded: The 2025 Nobel Prize in Physiology or Medicine went to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for discovering mechanisms of peripheral immune tolerance — i.e. how the immune system keeps itself in check outside of the central (thymic / bone marrow) tolerance checkpoints. ( Nature ) A central factor in that discovery is the role of regulatory...
Post a Comment
Read more

Misdiagnosed Minds: How AuDHD Is Mistaken for Disorders Like DID, Schizophrenia, and Mania

Misdiagnosed Minds: How AuDHD Is Mistaken for Disorders Like DID, Schizophrenia, and Mania Introduction Many neurodivergent individuals, especially those with combined Autism and ADHD (AuDHD), are misdiagnosed or overlooked entirely. This is particularly true when symptoms present in ways that mimic more "severe" psychiatric conditions like Dissociative Identity Disorder (DID), schizophrenia, or mania. The truth is: AuDHD—especially when layered with trauma, sensory overload, or chronic stress—can look like something else entirely to the untrained eye. And the consequences of misdiagnosis can be devastating. When the System Gets It Wrong Take for example a woman who was diagnosed with DID. Her complex personality traits, shifting moods, emotional intensity, and internal dialogues were interpreted as separate identities. But upon closer inspection, these could also be expressions of masking, trauma-induced role adaptation, emotional dysregulation, and sensory overwhelm—c...
Post a Comment
Read more

Prenatal Paracetamol Usage as a Proxy Marker for ADHD Susceptibility in Children?

Is Paracetamol (APAP) Usage During Pregnancy a Cause of ADHD – Or Just a Proxy Marker For ADHD Susceptibility? Rethinking a Recent Nature Study Linking APAP to Neurodevelopmental Risk A recent study published in Nature Mental Health (June 2025) has reignited debate about whether acetaminophen (paracetamol or APAP) taken during pregnancy could contribute to the development of attention deficit hyperactivity disorder (ADHD) in children. Using maternal blood biomarkers rather than self-reported medication use, the researchers reported that prenatal APAP exposure was associated with a more than threefold increase in ADHD diagnosis rates in offspring. The study also found that children of mothers who had detectable APAP levels during the second trimester showed altered placental gene expression — notably, upregulation of immune system genes and downregulation of oxidative phosphorylation pathways . These changes were especially prominent in female offspring and were linked to increased...
Post a Comment
Read more